Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M Hoare
Observed name:
M. Hoare
Observed institutions:
University of Leicester,
University of Oxford,
NIHR Leicester Biomedical Research Centre,
University College London,
Imperial College London
OpenAlex ID:
A5031989747
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021
·
Rachael A Evans
, Hamish J C McAuley
, et al.
·
The Lancet Respiratory Medicine
·
672
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022
·
R A Evans
, O C Leavy
, et al.
·
The Lancet Respiratory Medicine
·
413
PDF
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022
·
Felicity Liew
, Shubha Talwar
, et al.
·
EBioMedicine
·
121
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
2023
·
Callum Jackson
, Iain D Stewart
, et al.
·
The Lancet Respiratory Medicine
·
35
Accelerated immune ageing is associated with COVID-19 disease severity
2024
·
Janet M. Lord
, Tonny Veenith
, et al.
·
Immunity & Ageing
·
34
PDF
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
2023
·
Bang Zheng
, Giulia Vivaldi
, et al.
·
The Lancet Regional Health - Europe
·
29
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
2023
·
Hamish J.C. McAuley
, Rachael A. Evans
, et al.
·
EClinicalMedicine
·
24
PDF
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
2023
·
Omer Elneima
, Hamish J C McAuley
, et al.
·
International Journal of Epidemiology
·
23
PDF
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
2023
·
Maxime Taquet
, Zuzanna Skorniewska
, et al.
·
Brain Communications
·
14
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Long COVID research: an update from the PHOSP-COVID Scientific Summit
2023
·
Christopher E Brightling
, Rachael A Evans
, et al.
·
The Lancet Respiratory Medicine
·
11
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Show more works
View as search
Works count:
15
Citation count:
1,472
H-index:
12
I10-index:
13
Year
Topic
Type